Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited Medium: Print ISSN: 1520-9156 (Print) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE
    • Publication Information:
      Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., c1999-
    • Subject Terms:
      Blood Glucose Self-Monitoring/*methods ; Blood Glucose Self-Monitoring/*standards ; Diabetes Mellitus, Type 1/*blood ; Diabetes Mellitus, Type 2/*blood; Adult ; Blood Glucose Self-Monitoring/instrumentation ; Calibration ; Europe ; Humans ; Sensitivity and Specificity ; Societies, Medical ; Technology/standards ; United States
    • Abstract:
      Current clinical guidelines for diabetes care encourage self-monitoring of blood glucose (SMBG) to improve glycemic control. Specific protocols remain variable, however, particularly among non-insulin-using patients. This is due in part to efficacy studies that neglect to consider (1) the performance of monitoring equipment under real-world conditions, (2) whether or how patients have been taught to take action on test results, and (3) the physiological, behavioral, and social circumstances in which SMBG is carried out. As such, a multidisciplinary group of specialists, including several endocrinologists, a health psychologist, a diabetes nurse practitioner, and a patient advocate (the Panel), discuss within this review article how the potential of SMBG might be fully realized in today's healthcare environment. The resulting recommendations cover technological, clinical, behavioral, and research considerations with the aim of achieving short- and long-term benefits, ranging from fewer hypoglycemic episodes to lower complication-related costs. The panel also made suggestions for designing future studies that increase the ability to discern optimal models of SMBG utilization for individuals with diabetes who may, or may not, use insulin.
    • Number of References:
      130
    • Publication Date:
      Date Created: 20081022 Date Completed: 20090226 Latest Revision: 20220408
    • Publication Date:
      20231215
    • Accession Number:
      10.1089/dia.2008.0104
    • Accession Number:
      18937550